| Authors: |
Mitchell J; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden. joseph.mitchell@ki.se.; The ISoP Special Interest Group On Ecopharmacovigilance, London, UK. joseph.mitchell@ki.se.; Uppsala Monitoring Centre, Uppsala, Sweden. joseph.mitchell@ki.se., Maza Larrea J; Uppsala Monitoring Centre, Uppsala, Sweden., Dzidzornu ED; The ISoP Special Interest Group On Ecopharmacovigilance, London, UK.; Independent Researcher, Accra, Ghana., Pandit J; The ISoP Special Interest Group On Ecopharmacovigilance, London, UK.; Pharmacovigilance & Patient Safety Consultant, Nairobi, Kenya., Cherian JJ; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; The ISoP Special Interest Group On Ecopharmacovigilance, London, UK.; Indian Council of Medical Research, New Delhi, India., Massouh R; The ISoP Special Interest Group On Ecopharmacovigilance, London, UK.; GSK, London, UK. |
